
The University of Oxford has unveiled exciting new data in the treatment of the novel coronavirus, with a randomised clinical …

Amgen (NASDAQ: AMGN) has presented data showing a statistically significant increase in progression-free survival and overall response rate in multiple …

Genmab has announced that positive results from a Phase III trial evaluating Darzalex (daratumumab), which is being developed in partnership …

MSD has announced that it has initiated two Phase III studies based in part on the strength of early data, …

